4.7 Article

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Therapeutic Drug Monitoring in the Treatment of Tuberculosis: An Update

Abdullah Alsultan et al.

Review Medicine, General & Internal

Defining antibiotic resistance-towards international harmonization

Gunnar Kahlmeter

UPSALA JOURNAL OF MEDICAL SCIENCES (2014)

Article Public, Environmental & Occupational Health

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis

Kristian Angeby et al.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)

Article Infectious Diseases

Drug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions

Senia Rosales-Klintz et al.

INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY (2012)

Review Infectious Diseases

Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

Kwok Chiu Chang et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)

Article Microbiology

Population pharmacokinetics of levofloxacin, gatifloxacin, and moxifloxacin in adults with pulmonary tuberculosis

Charles A. Peloquin et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)